Harga Saham
154.98
Perubahan Harian
3.17 2.09%
Bulanan
24.91%
Tahunan
48.90%
Q1 Perkiraan
147.82




Ebitda Perubahan Tanggal
AbbVie USD 3.52B 828M 2025-09
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
ALKERMES USD 121.55M 4.99M 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amgen USD 5.14B 775M 2025-12
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Coherus Biosciences USD -44.34M 9.82M 2025-03
Eli Lilly USD 7.88B 378.1M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Incyte USD 506.92M 74.6M 2025-09
J&J USD 9.52B 389M 2025-09
Merck USD 8.39B 1.97B 2025-09
Moderna USD -790M 582M 2025-12
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 5.88B 290M 2025-09
Pfizer USD 6.08B 351M 2025-09
PTC Therapeutics USD -33.11M 1B 2025-06
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Sanofi EUR 4.84B 2.95B 2025-09
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
United Therapeutics USD 436.8M 34.2M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


Gilead Sciences - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Feb 2026.